Today: 30 June 2026
Browse Category

NASDAQ:KLAC 1 January 2026 - 14 January 2026

Applied Materials stock drops despite Stifel’s $340 target hike — what AMAT investors watch next

Applied Materials stock drops despite Stifel’s $340 target hike — what AMAT investors watch next

New York, Jan 14, 2026, 11:55 ET — Regular session Applied Materials slipped 1.8%, hitting $299.25 by midday Wednesday, despite Stifel lifting its price target from $250 to $340. Stifel analyst Brian Chin cited “bullish” field checks in recent weeks and now projects wafer fab equipment spending to rise 10%-15% in calendar 2026.
14 January 2026
····
KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

New York, Jan 12, 2026, 21:02 ET — Market closed KLA Corp shares climbed 2.0% Monday, closing at $1,428.17—a fresh 52-week high that topped the previous peak of $1,406.97 from Jan. 6. Trading volume hit 854,084 shares, below the 50-day average, even as the S&P 500 and Dow finished slightly higher. Applied Materials jumped roughly 2.0%, while Lam Research added nearly 1.0%, boosting the iShares Semiconductor ETF by about 0.5%.
13 January 2026
··
Lam Research stock (LRCX) jumps on Mizuho target hike — what to watch into Monday and the week ahead

Lam Research stock (LRCX) jumps on Mizuho target hike — what to watch into Monday and the week ahead

New York, January 11, 2026, 14:32 ET — The market is now closed. Shares of Lam Research surged 8.7% on Friday following Mizuho’s boost of its price target to $220 from $200. The PHLX semiconductor index climbed 2.7%, hitting a new high. “Investors are getting granular and picking the winners and losers,” said Zachary Hill, head of portfolio management at Horizon Investments.
11 January 2026
····
KLA (KLAC) stock rises after Cantor upgrade as CES AI headlines keep chip tools in focus

KLA (KLAC) stock rises after Cantor upgrade as CES AI headlines keep chip tools in focus

New York, Jan 6, 2026, 13:26 EST — Regular session KLA Corp shares rose 3.4% to $1,398.66 in afternoon trading on Tuesday after Cantor Fitzgerald upgraded the $187 billion process-control toolmaker and lifted its price target. Cantor analyst C.J. Muse raised the rating to “overweight” from “neutral” and increased the target to $1,500 from $1,350, according to MarketScreener and StreetInsider.
6 January 2026
····
1 … 3 4 5 6 7

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Go toTop